Helen M. Boudreau's most recent trade in Rallybio Corp was a trade of 3,562 Common Stock done at an average price of $2.4 . Disclosure was reported to the exchange on July 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rallybio Corp | Helen M. Boudreau | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share. | 06 Jul 2026 | 3,562 | 6,542 | - | 2.4 | 8,478 | Common Stock |
| Rallybio Corp | Helen M. Boudreau | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2026 | 3,562 | 0 | - | - | Option (Right to Buy) | |
| Shattuck Labs Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2026 | 81,000 | 81,000 | - | - | Stock Option (Right to Buy) | |
| Premier Inc (Class A) | Helen M. Boudreau | Director | Sale or transfer of securities back to the company at price $ 28.25 per share. | 25 Nov 2025 | 18,668 | 0 (0%) | 0% | 28.3 | 527,371 | Class A Common Stock |
| Shattuck Labs Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 33,150 | 33,150 | - | - | Stock Option (Right to Buy) | |
| Premier Inc (Class A) | Helen M. Boudreau | Director | Sale of securities on an exchange or to another person at price $ 22.88 per share. | 30 May 2025 | 2,000 | 18,668 (0%) | 0% | 22.9 | 45,760 | Class A Common Stock |
| Rallybio Corp | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 28,500 | 28,500 | - | - | Option (Right to Buy) | |
| Premier Inc (Class A) | Helen M. Boudreau | Director | Sale of securities on an exchange or to another person at price $ 21.42 per share. | 06 Jan 2025 | 2,500 | 20,668 (0%) | 0% | 21.4 | 53,550 | Class A Common Stock |
| Premier Inc (Class A) | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2024 | 7,101 | 23,168 (0%) | 0% | 0 | Class A Common Stock | |
| Shattuck Labs Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 27,700 | 27,700 | - | - | Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 150,647 | 150,647 (0%) | 0% | 0 | Common Stock | |
| Rallybio Corp | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 16,500 | 16,500 | - | - | Option (Right to Buy) | |
| Premier Inc (Class A) | Helen M. Boudreau | Director | Sale of securities on an exchange or to another person at price $ 19.85 per share. | 15 May 2024 | 6,629 | 16,067 (0%) | 0% | 19.9 | 131,586 | Class A Common Stock |
| Premier Inc (Class A) | M. Helen Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 7,333 | 22,696 (0%) | 0% | 0 | Class A Common Stock | |
| Shattuck Labs Inc | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 40,258 | 40,258 | - | - | Stock Option (Right to Buy) | |
| Premier Inc (Class A) | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2022 | 4,636 | 15,363 (0%) | 0% | 0 | Class A Common Stock | |
| Rallybio Corp | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 13,440 | 13,440 | - | - | Option (Right to Buy) | |
| Premier Inc (Class A) | Helen M. Boudreau | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Dec 2021 | 4,098 | 10,727 (0%) | 0% | 0 | Class A Common Stock |